Financials
Financial year 2025
Neapharma from Herzele, company number BE0632635978, closed financial year 2025 with a result of € -5,946 after tax. For that financial year Neapharma recorded a gross margin of € 28,649 and equity of € 112,022. Compared with financial year 2024, the result moved from € 9,244 to € -5,946. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.
€ 112,022
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -5,946
▼ still € 9,244 profit in 2024
Profit after tax over the fiscal year.
€ 51,041
▲ 218% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 97,022.
People and assets in 2025
€ 3,373
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 56,667
▲ 93% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 617
▼ 91% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 33,117 | € 64,295 | € 28,662 | € 28,649 | |
| Profit after taxes | € 12,579 | € 31,905 | € 9,244 | € -5,946 | ▼ € 15,190 |
| Equity | € 76,820 | € 108,725 | € 117,969 | € 112,022 | ▼ 5% |
| Total debts | € 93,723 | € 97,271 | € 88,355 | € 109,340 | ▲ 24% |
| Cash | € 31,292 | € 42,751 | € 16,068 | € 51,041 | ▲ 218% |
| Retained profit | € 61,820 | € 93,725 | € 102,969 | € 97,022 | ▼ 6% |
| Bank debt | € 14,910 | € 9,039 | € 3,045 | € 0 | ▼ 100% |
| Balance sheet total | € 170,543 | € 205,996 | € 206,324 | € 221,363 | ▲ 7% |
Key figures of Neapharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Neapharma?
What happened at Neapharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 5,946 (▼ € 15,190 vs 2024). Source: NBB ↗
- Kristof De Kegel became a director. NBB
- Olivier Van Baeveghem became a director. NBB
- Kjell De Potter became a director. NBB
- New establishment in Oudenaarde. KBO
- New establishment in Herzele. KBO
- Start of the company according to the CBE. KBO
In short
From € 12,579 profit in 2022 to € 5,946 loss in 2025.
Paid € 23,975 in corporate taxes since 2022.
Best year ever: 2023, with € 31,905 profit.
Management
Behind Neapharma are Kristof De Kegel, Olivier Van Baeveghem and Kjell De Potter. Kristof De Kegel is also behind Kristof De Kegel.
Directors
According to the 2025 annual accounts
since 2023
Olivier Van Baeveghem
Director
since 2023
Kjell De Potter
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Provincieweg 410
9550 Herzele
Meersbloem-Melden 46 box 1
9700 Oudenaarde
Active since 1 December 2022
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
COMBELL-AS, BE
Website info
Features
Security
Network
Details
- Company number
- 0632.635.978
- VAT number
- BE 0632.635.978
- Registered office
- Provincieweg 410, 9550 Herzele
- Names & denominations
- Neapharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 June 2015
- Peppol
- Active · Active since 27 Jun 2025
- Contact
- neapharma.be
- Activities · NACE
Overige detailhandel in voedingsmiddelen, neg
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.
Detailhandel in fietsen
Detailhandel in fietsen in gespecialiseerde winkels